ERBB2 and gastric cancer: Furthermore, phase II trials of oral S-1 plus cisplatin with trastuzumab as first-line chemotherapy and a combination of paclitaxel plus trastuzumab as second-line chemotherapy in trastuzumab naïve patients with HER2-positive metastatic GC were performed in Japan [11, 12].